# Alcohol-Induced Neuroleptic Malignant Syndrome Complicated by Severe Acute Rhabdomyolysis

**Authors:** Juan R Santos-Rivera, Regina J McPherson, Guillermo Izquierdo-Pretel

PMC · DOI: 10.7759/cureus.81786 · Cureus · 2025-04-06

## TL;DR

A 22-year-old man developed a rare alcohol-induced neuroleptic malignant syndrome and severe rhabdomyolysis after drinking, highlighting the need for early recognition and treatment.

## Contribution

This case report presents a rare instance of alcohol-induced NMS complicated by severe rhabdomyolysis.

## Key findings

- The patient had a CPK level exceeding 100,000 U/L, indicating severe rhabdomyolysis.
- Alcohol consumption is suggested as a trigger for NMS in the context of lithium treatment.
- Early recognition and multidisciplinary management are critical to prevent fatal outcomes.

## Abstract

This case highlights a rare instance of alcohol-induced neuroleptic malignant syndrome (NMS) complicated by acute severe rhabdomyolysis, emphasizing the importance of recognizing atypical presentations of NMS. In June 2024, a 22-year-old male presented to the emergency department of a tertiary hospital in Florida with an acute alteration in mental status following alcohol consumption. Physical examination revealed neurological deficits alongside significant vital signs, including a temperature of 38°C, tachycardia, and hypertension. Key laboratory findings included a creatinine phosphokinase (CPK) level exceeding 100,000 U/L, aspartate aminotransferase (AST) above 3,000 U/L, alanine aminotransferase (ALT) above 500 U/L, and a lithium level below 0.20 mmol/L. The patient's medical history of bipolar disorder, managed with lithium, and recent alcohol intake suggest alcohol's role as a trigger for NMS in the context of lithium treatment, compounded by severe rhabdomyolysis. This case underscores the need for heightened clinical awareness of such complex interactions and highlights the critical importance of early recognition and multidisciplinary management to prevent potentially fatal complications.

## Linked entities

- **Chemicals:** lithium (PubChem CID 28486)
- **Diseases:** bipolar disorder (MONDO:0004985), neuroleptic malignant syndrome (MONDO:0019790), rhabdomyolysis (MONDO:0005290)

## Full-text entities

- **Genes:** SLC17A5 (solute carrier family 17 member 5) [NCBI Gene 26503] {aka AST, ISSD, NSD, SD, SIALIN, SIASD}, GPT (glutamic--pyruvic transaminase) [NCBI Gene 2875] {aka AAT1, ALT, ALT1, GPT1, SGPT}
- **Diseases:** neurological deficits (MESH:D009461), tachycardia (MESH:D013610), bipolar disorder (MESH:D001714), NMS (MESH:D009459), hypertension (MESH:D006973), Rhabdomyolysis (MESH:D012206)
- **Chemicals:** Alcohol (MESH:D000438), lithium (MESH:D008094)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12054776/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12054776/full.md

## References

13 references — full list in the complete paper: https://tomesphere.com/paper/PMC12054776/full.md

---
Source: https://tomesphere.com/paper/PMC12054776